QLVD - ETF AI Analysis
Top Page
FlexShares Developed Markets ex-US Quality Low Volatility Index Fund (QLVD)
QLVD, the FlexShares Developed Markets ex-US Quality Low Volatility Index Fund, appears to offer solid overall quality by focusing on financially strong, stable companies outside the U.S. Top holdings like Novartis, DBS Group, and Zurich Insurance Group support the fund’s rating through robust profitability, positive earnings sentiment, and reasonable valuations with attractive dividends. The main risk is that some holdings show signs of overbought or bearish technical trends and high debt or leverage, which could lead to short-term volatility despite the fund’s low-volatility focus.
QLVD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 53.68M
- Region
- Developed Markets
- Expense Ratio
- 0.12%
- Beta
- 0.36
- Issuer
- Northern Trust
- Inception Date
- Jul 15, 2019
- Dividend Yield
- 2.98%
- Asset Class
- Equity
- Index Tracked
- Northern Trust Developed Markets ex-US Quality Low Volatility Index
QLVD Summary
QLVD is an exchange-traded fund that follows the Northern Trust Developed Markets ex-US Quality Low Volatility Index. It invests in a wide mix of companies from developed countries outside the U.S., aiming for steady performance with less dramatic price swings. The fund holds well-known names like Novartis, Nestlé, Unilever, and Royal Bank of Canada, giving investors broad international diversification in one investment. Someone might consider QLVD if they want global stock exposure with a focus on financially strong, more stable companies. A key risk is that it still invests in stocks, so its value can go up and down with global markets.
How much will it cost me?
This ETF has an expense ratio of 0.12%, which means you’ll pay about $1.20 per year for every $1,000 you invest. That’s lower than the average stock ETF because it’s passively managed and tracks an index rather than paying a team to actively pick stocks.
What would affect this ETF?
QLVD could benefit if developed markets outside the U.S. grow steadily, especially in sectors like financials, consumer defensive, and health care, and if investors continue to favor lower-volatility, high-quality companies such as Novartis, Nestlé, and Royal Bank of Canada. On the negative side, global economic slowdowns, rising interest rates that pressure banks, currency swings between foreign markets and the U.S. dollar, or regulatory changes affecting large international firms and energy companies like Shell could weigh on future returns.
QLVD Top 10 Holdings
QLVD leans heavily on steady, blue-chip names outside the U.S., with Novartis and ASML acting as key engines for performance—Novartis rising on solid fundamentals and ASML powering ahead as a semiconductor standout despite some recent choppiness. Big Canadian banks like Royal Bank of Canada and Canadian Bank of Commerce add a financial backbone, with generally rising trends but occasional pauses. Consumer staples such as Unilever and Nestlé are more mixed, sometimes losing steam, which can gently tug on returns. Overall, it’s a diversified, developed-markets ex-U.S. mix with no single stock dominating the story.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Novartis AG | 4.26% | $2.26M | CHF 244.89B | 35.30% | 80Outperform | |
| Royal Bank Of Canada | ― | ― | ― | ― | 75Outperform | |
| ASML Holding NV | 2.31% | $1.22M | EUR 539.67B | 50.70% | 76Outperform | |
| Unilever | 2.26% | $1.20M | GBP 104.93B | -6.01% | 72Outperform | |
| DBS Group Holdings | ― | ― | ― | ― | 78Outperform | |
| Canadian Bank of Commerce | 1.81% | $958.49K | CAD 147.95B | 41.39% | 74Outperform | |
| Iberdrola | 1.67% | $887.91K | EUR 146.27B | 26.31% | 67Neutral | |
| Shell (UK) | 1.67% | $885.58K | GBP 229.30B | 40.01% | 73Outperform | |
| Nestlé SA | 1.60% | $850.68K | CHF 217.87B | 9.36% | 71Outperform | |
| Zurich Insurance Group | 1.54% | $815.41K | CHF 92.06B | 9.99% | 78Outperform |
QLVD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For QLVD, the sentiment is Positive. The current price of 34.71 is above the 20-day moving average (MA) of 33.84, above the 50-day MA of 33.92, and above the 200-day MA of 33.04, indicating a bullish trend. The MACD of 0.30 indicates Negative momentum. The RSI at 66.05 is Neutral, neither overbought nor oversold. The STOCH value of 87.81 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for QLVD.
QLVD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| $34.71 | $37.00(6.59% Upside) | $53.68M | 0.12% | 68Neutral | |
| $39.03 | $46.42(18.93% Upside) | $92.71M | 0.45% | 66Neutral | |
| $37.06 | $45.97(24.05% Upside) | $60.41M | 0.03% | 61Neutral | |
| $39.44 | $45.17(14.54% Upside) | $55.41M | 0.24% | 59Neutral | |
| $35.71 | $40.37(13.04% Upside) | $34.83M | 0.48% | 70Outperform | |
| $27.29 | $32.29(18.32% Upside) | $20.54M | 0.42% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| QLVD | FlexShares Developed Markets ex-US Quality Low Volatility Index Fund | 34.71 | 4.90 | 16.42% | |
| INEQ | Columbia International Equity Income Etf | 39.03 | 4.88 | 14.29% | |
| DMXU | Xtrackers Bloomberg Developed Markets ex US Equity ETF | 37.05 | 3.35 | 9.94% | |
| DEEF | Xtrackers FTSE Developed ex US Multifactor ETF | 39.44 | 5.62 | 16.61% | |
| OEFA | O'Shares International Developed Quality Dividend ETF | 35.71 | 3.14 | 9.65% | |
| RWIN | Rayliant NxtGen Multifactor International Equity ETF | 27.29 | 1.57 | 6.08% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.